Cargando…
Selective release of gastrointestinal hormones induced by an orally active GPR39 agonist
OBJECTIVES: Obesity is a complex disease associated with a high risk of comorbidities. Gastric bypass surgery, an invasive procedure with low patient eligibility, is currently the most effective intervention that achieves sustained weight loss. This beneficial effect is attributed to alterations in...
Autores principales: | Grunddal, Kaare V., Diep, Thi A., Petersen, Natalia, Tough, Iain R., Skov, Louise J., Liu, Lingzhi, Buijink, Jesse A., Mende, Franziska, Jin, Chunyu, Jepsen, Sara L., Sørensen, Louis M.E., Achiam, Michael P., Strandby, Rune B., Bach, Anders, Hartmann, Bolette, Frimurer, Thomas M., Hjorth, Siv A., Bouvier, Michel, Cox, Helen, Holst, Birgitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042403/ https://www.ncbi.nlm.nih.gov/pubmed/33711555 http://dx.doi.org/10.1016/j.molmet.2021.101207 |
Ejemplares similares
-
The Zinc-Sensing Receptor GPR39 in Physiology and as a Pharmacological Target
por: Laitakari, Anna, et al.
Publicado: (2021) -
β-Cell Specific Overexpression of GPR39 Protects against Streptozotocin-Induced Hyperglycemia
por: Egerod, Kristoffer L., et al.
Publicado: (2011) -
Receptor structure-based discovery of non-metabolite agonists for the succinate receptor GPR91
por: Trauelsen, Mette, et al.
Publicado: (2017) -
GPR39 (Zinc Receptor) Knockout Mice Exhibit Depression-Like Behavior and CREB/BDNF Down-Regulation in the Hippocampus
por: Młyniec, Katarzyna, et al.
Publicado: (2015) -
GPR39 deorphanization: The long and winding road to eicosanoids and a crosstalk between GPR39 and hedgehog signaling in angiogenesis
por: Doboszewska, Urszula, et al.
Publicado: (2023)